Soma Sengupta
#186,605
Most Influential Person Now
British-American neurologist
Soma Sengupta's AcademicInfluence.com Rankings
Soma Senguptamedical Degrees
Medical
#3874
World Rank
#4400
Historical Rank
Neurology
#357
World Rank
#461
Historical Rank
Download Badge
Medical
Soma Sengupta's Degrees
- PhD Neurology University of Oxford
- Doctorate Neurology Harvard University
Why Is Soma Sengupta Influential?
(Suggest an Edit or Addition)According to Wikipedia, Soma Sengupta, MD, PhD, MBA, FRCP, FANA, FAAN is a British-American physician-scientist. She is a specialty board certified neuro-oncologist board certified Neurologist, fellowship-trained in Integrative Medicine, and recipient of an MBA. Her clinical interests span treatment of brain tumor patients, integrative approaches in neurology and oncology, as well as healthcare policy. She is a full-time faculty member of the Department of Neurology at the University of North Carolina at Chapel Hill, where she is a Full Professor, Vice Chair, and Chief of the Division of Neuro-Oncology. She is also a Bye Fellow at Lucy Cavendish College, University of Cambridge, U.K.
Soma Sengupta's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS (2012) (686)
- Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma (2012) (152)
- Imaging of Neurologic Disease in Hospitalized Patients with COVID-19: An Italian Multicenter Retrospective Observational Study (2020) (133)
- Rapid discrimination of pediatric brain tumors by mass spectrometry imaging (2018) (40)
- α5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth (2014) (36)
- The evolution of medulloblastoma therapy to personalized medicine (2017) (31)
- Stereotactic Radiosurgery for Renal Cancer Brain Metastasis: Prognostic Factors and the Role of Whole-Brain Radiation and Surgical Resection (2015) (26)
- First In Vivo Testing of Compounds Targeting Group 3 Medulloblastomas Using an Implantable Microdevice as a New Paradigm for Drug Development. (2016) (26)
- Single-cell analysis reveals effective siRNA delivery in brain tumors with microbubble-enhanced ultrasound and cationic nanoparticles (2021) (24)
- Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis (2021) (22)
- Pilot Feasibility Study of an Oncology Financial Navigation Program in Brain Cancer Patients. (2019) (22)
- Impact of Sequencing Radiation Therapy and Immune Checkpoint Inhibitors in the Treatment of Melanoma Brain Metastases. (2020) (21)
- Modulating native GABAA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death (2019) (16)
- Dosimetric analysis of the alopecia preventing effect of hippocampus sparing whole brain radiation therapy (2015) (15)
- Melanoma Cell Intrinsic GABAA Receptor Enhancement Potentiates Radiation and Immune Checkpoint Inhibitor Response by Promoting Direct and T Cell-Mediated Antitumor Activity. (2020) (15)
- Intracranial artery dissection in an adolescent with Marfan syndrome. (2011) (15)
- Gliosarcoma: distinct molecular pathways and genomic alterations identified by DNA copy number/SNP microarray analysis (2019) (15)
- Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial (2020) (13)
- First evidence of pathogenicity of V234I mutation of hVAPB found in Amyotrophic Lateral Sclerosis. (2014) (13)
- Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification (2020) (12)
- A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastoma (2022) (9)
- Posterior reversible encephalopathy syndrome (PRES) complicating newly-diagnosed diffuse large B-cell lymphoma. (2014) (7)
- Implementation of cell-free tumor DNA sequencing from the cerebrospinal fluid to guide treatment in a patient with primary leptomeningeal melanoma: A case report. (2018) (7)
- Complete Response of a Patient With a Mismatch Repair Deficient Aggressive Pituitary Adenoma to Immune Checkpoint Inhibitor Therapy: A Case Report (2022) (6)
- Therapeutically leveraging GABAA receptors in cancer (2021) (6)
- Brain cancer genomics and epigenomics. (2018) (5)
- Sacral Epidural Anesthesia. (2014) (5)
- Interdisciplinary Approaches to Survivorship with a Focus on the Low-grade and Benign Brain Tumor Populations (2021) (5)
- Recurrence of herpes simplex encephalitis associated with temozolomide chemoradiation for malignant glioma: a case report and review of the literature (2014) (4)
- Combination of Fascia Iliaca Compartment Block on the Surgical Side with Sacral Spinal Anesthesia for Hip to Knee Surgery (2014) (4)
- Novel use of dual immunomodulation for treating stiff‐person syndrome, cerebellar variant (2013) (4)
- A Case Study Using Papaya Leaf Extract to Reverse Chemotherapy-Induced Thrombocytopenia in a GBM Patient (2022) (4)
- Role of Preoperative Fascia Iliaca Compartment Block On The Side Of Femur Surgery (2014) (3)
- Could α5-GABA-A receptor activation be used as a target for managing medulloblastomas? (2014) (3)
- Advances in Immunotherapy for the Treatment of Adult Glioblastoma: Overcoming Chemical and Physical Barriers (2022) (2)
- Reuse of Molecules for Glioblastoma Therapy (2021) (2)
- Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma (2021) (2)
- Epigenetics and survivorship in pediatric brain tumor patients (2020) (2)
- Combination of Sacral Spinal Anesthesia and Popliteal Fossa Block on Surgical Side for Below Knee Surgery (2014) (2)
- Illusion of stroke: intravascular lymphomatosis. (2011) (2)
- The role of erlotinib and the Optune device in a patient with an epidermal growth factor receptor viii amplified glioblastoma (2018) (2)
- Presentation of treatment effect in glioblastoma after dose-escalation radiation therapy (2019) (2)
- Sacral Saddle Block for Day Care and Ambulatory Surgery in Anorectal Procedure. (2014) (2)
- Intentional Unilateral Sacral Epidural (2014) (2)
- Integration of Molecular Analysis, Cutting-edge Mouse Genetic Models and Proton Therapy to Improve Outcomes for Glioma Patients (2021) (1)
- Implicating Gene and Cell Networks Responsible for Differential COVID-19 Host Responses via an Interactive Single Cell Web Portal (2021) (1)
- EXTH-12. RADIATION ENHANCES MELANOMA RESPONSE TO IMMUNOTHERAPY AND SYNERGIZES WITH BENZODIAZEPINES TO PROMOTE ANTI-TUMOR ACTIVITY (2019) (1)
- Brain tumors and pregnancy (2015) (1)
- The Benefit of Palliative Care on Brain Cancer Patients’ Quality of Life (2018) (1)
- Neurological Manifestations and Neuroimaging Features of COVID-19 Patients: A Multicenter Italian Experience (2020) (1)
- Spinal At T10 (10 th Thoracic) (2014) (1)
- Angiogenesis inhibitors in brain cancer treatment (2014) (1)
- Abstract 247: Identification of the GABAAreceptor in melanoma brain metastases patient tumors and demonstration that it is a viable drug target using benzodiazepine-derivatives (2019) (0)
- NIMG-30. ASSESSING TREATMENT RESPONSE OF GLIOBLASTOMA TO AN HDAC INHIBITOR, BELINOSTAT (PXD101) (2017) (0)
- PDTB-28. TARGETING MEDULLOBLASTOMA WITH BENZODIAZAPINES DELIVERED USING TUNABLE BIODEGRADABLE HYDROGELS (2016) (0)
- The timing of chemoradiotherapy after surgical resection and its impact on overall survival in glioblastoma. (2019) (0)
- CTNI-17. A MULTI-INSTITUTIONAL RANDOMIZED CLINICAL TRIAL COMPARING ASSAY - GUIDED CHEMOTHERAPY WITH PHYSICIAN-CHOICE TREATMENT FOR RECURRENT HIGH-GRADE GLIOMA (NCT03632135) (2022) (0)
- CSIG-16. EXPLOITING A NEGATIVE FEEDBACK LOOP LINKING S6 KINASES AND AXL TO REDUCE PYRIMIDINE BIOSYNTHESIS IN PTEN-DEFICIENT GLIOBLASTOMA (2022) (0)
- CTNI-34. INITIAL ANALYSIS OF PHASE-III TRIAL - STANDARD CHEMOTHERAPY VS. CHEMOTHERAPY GUIDED BY A CANCER STEM CELL TEST IN RECURRENT GLIOBLASTOMA (NCT03632135) (2020) (0)
- RBIO-01. ACTIVATING AN ION CHANNEL PROMOTES RADIATION-SENSITIZING IMMUNE-DRIVEN ANTI-TUMOR ACTIVITY (2022) (0)
- Potentiation of temozolomide activity against glioblastoma cells by aromatase inhibitor letrozole (2022) (0)
- Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial. (2023) (0)
- Pearls & Oy-sters: Pivoting Treatment Regimens of Pediatric Atypical Teratoid Rhabdoid Tumors to Optimize Care in Adult ATRT: A Case Report (2022) (0)
- Faculty Opinions recommendation of Active medulloblastoma enhancers reveal subgroup-specific cellular origins. (2017) (0)
- Frequency of Coincident Iron Deficiency among Children with Β Thalassemia Trait (2015) (0)
- ET-24A NOVEL TROJAN HORSE FOR IN-VIVO SENSITIVITY TESTING OF MEDULLOBLASTOMA THERAPIES. (2014) (0)
- Dosimetric analysis of the alopecia preventing effect of hippocampus sparing whole brain radiation therapy (2015) (0)
- Abstract 255: Antagonizing Na-K-Cl cotransporter NKCC1 impairs medulloblastoma cell viability (2019) (0)
- Axillary Block through Its Anterior Fold- A New Approach (2015) (0)
- Pediatric cerebellar tumors: transcriptionally distinct but developmentally heterogeneous (2020) (0)
- Redefining Management of Adult Low-Grade Gliomas. (2016) (0)
- Biological and prognostic relevance of epigenetic regulatory genes in high-grade gliomas (HGGs). (2022) (0)
- Bevacizumab and Optune Combination in Treating Newly Diagnosed GBM: Case Study (2020) (0)
- MRI findings in trigeminal neuropathy: bilateral Meckel’s cave lesions (2019) (0)
- High-Grade Tumors of the Brainstem (Except DIPG) (2020) (0)
- Case report Recurrence of herpes simplex encephalitis associated with temozolomide chemoradiation for malignant glioma : a case report and review of the literature (2014) (0)
- EXTH-99. SYSTEMIC AND BRAIN PHARMACOKINETICS OF A GABAA RECEPTOR AGONIST, AMLAL-101, AS AN INVESTIGATIONAL THERAPEUTIC FOR THE TREATMENT OF PRIMARY AND METASTATIC BRAIN CANCERS (2022) (0)
- Abstract 2623: Modulating native GABAAreceptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death (2019) (0)
- COMP-22. LARGE SCALE TRANSCRIPTOMIC ANALYSIS OF MELANOMA BRAIN METASTASES (2018) (0)
- MRI findings in trigeminal neuropathy: bilateral Meckel’s cave lesions (2019) (0)
- Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target. (2022) (0)
- RBIO-02. ACTIVATION OF GABAA RECEPTORS WITH A NON-TOXIC, BRAIN PENETRANT SMALL MOLECULE SENSITIZES LUNG ADENOCARCINOMA PRIMARY AND BRAIN METASTATIC TUMOR CELLS TO RADIATION VIA AUTOPHAGY INDUCTION (2022) (0)
- Abstract CT224: Multi-institutional randomized phase-3 trial comparing cancer stem cell-targeted vs physician-choice treatments in patients with recurrent high-grade gliomas (NCT03632135) (2022) (0)
- PDTM-45. POSITIVE MODULATION OF NATIVE GABAA RECEPTORS IN MEDULLOBLASTOMA CANCER CELLS WITH BENZODIAZEPINES INDUCES RAPID MITOCHONDRIAL FRAGMENTATION AND TP53-DEPENDENT, CELL CYCLE-INDEPENDENT APOPTOSIS (2018) (0)
- Faculty Opinions recommendation of Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032. (2017) (0)
- Integrative neuro-oncology for brain tumor patients. (2023) (0)
- SYST-07. PILOT STUDY UTILIZING THE HDAC INHIBITOR BELINOSTAT WITH CHEMORADIATION FOR NEWLY-DIAGNOSED GLIOBLASTOMA (2021) (0)
- PRECLINICAL EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY (2010) (0)
- F1000Prime recommendation of Molecular pathology of paediatric central nervous system tumours. (2017) (0)
- 20. MELANOMA CELL INTRINSIC GABAA RECEPTOR ENHANCEMENT POTENTIATES RADIATION AND IMMUNE CHECKPOINT INHIBITOR RESPONSE BY PROMOTING DIRECT AND T CELL-MEDIATED ANTI-TUMOR ACTIVITY (2020) (0)
- PATH-10. COPY NUMBER (CN)/SINGLE NUCLEOTIDE POLYMORPHISM (SNP) MICROARRAY ANALYSIS OF THE EGFR LOCUS IN GLIOSARCOMA (2018) (0)
- Abstract PO-009: Targeting a unique electrochemical vulnerability in a pediatric brain tumor to potentiate proton beam radiotherapy (2021) (0)
- EPCT-25. SMO PROTEIN DEPLETION IN SHH MEDULLOBLASTOMAS USING MICROBUBBLE-ENHANCED ULTRASOUND AND SIRNA LOADED CATIONIC NANOPARTICLES (2021) (0)
- W190 PREGNANCY IN ELDERLY (2012) (0)
- Faculty Opinions recommendation of SHH inhibitors for the treatment of medulloblastoma. (2017) (0)
- CTNI-13. UPDATES ON CLINICAL OUTCOMES AND TUMOR RECURRENCE PATTERNS OF A HUMAN PILOT STUDY ASSESSING EFFICACY OF BELINOSTAT (PXD-101) COMBINING WITH CHEMORADIATION IN TREATING GLIOBLASTOMA (2020) (0)
- Sacral Unilateral Spinal Anaesthesia With 0.25% Hypobaric Bupivacaine (2015) (0)
- PATH-50. UNDERSTANDING THE MECHANISM OF BENZODIAZEPINE MEDIATED CELL DEATH IN GABRA5 OVEREXPRESSING GROUP 3 MEDULLOBLASTOMAS (2017) (0)
- PATH-03. “DEDIFFERENTIATED” GLIOBLASTOMA: A CLINICOPATHOLOGICAL AND MOLECULAR STUDY (2017) (0)
- 68th Annual Cancer Symposium (2015) (0)
- SYST-01 MULTI-INSTITUTIONAL RANDOMIZED TRIAL COMPARING CANCER STEM CELL-TARGETED VS PHYSICIAN-CHOICE TREATMENTS IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS (NCT03632135) (2022) (0)
- QOL-18. CAN QUALITY OF LIFE FOR BRAIN TUMOR SURVIVORSHIP CARE (2022) (0)
- INNV-42. ACTIVE VS RECEPTIVE MUSIC LISTENING THERAPY IN BREAST CANCER PATIENTS USING ARMCAN (2021) (0)
- Lessons learned from evolving frameworks in adult glioblastoma. (2023) (0)
- PATH-04. DISTINGUISHING PINEOBLASTOMA FROM MEDULLOBLASTOMAS USING TISSUE MASS SPECTROMETRY IMAGING. (2017) (0)
This paper list is powered by the following services:
Other Resources About Soma Sengupta
What Schools Are Affiliated With Soma Sengupta?
Soma Sengupta is affiliated with the following schools:
